What is LOPJLB’s current signal on SGMT?

LOPJLB’s latest quantitative signal on Sagimet Biosciences Inc. (SGMT) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is SGMT in?

Sagimet Biosciences Inc. (SGMT) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Sagimet Biosciences Inc. (SGMT) do?

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The companyâs lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dy…

Where is Sagimet Biosciences Inc. based / listed?

Sagimet Biosciences Inc. is based in US, listed on NASDAQ.

Sagimet Biosciences Inc. (SGMT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$8.93+0.11%Close

SELLCRISIS · day 12

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $291M
Beta: 3.49
P/E (TTM): -6.84

Short % float: 35.85%
Days to cover: 6.7
SI change: +9.0%

1W: -2.30%
1M: -19.26%

vs SPY 1W: -3.46%
vs SPY 1M: -22.25%

Industry peers

FMP comparable companies · ranked by market cap

ACHVSELLAchieve Life Sciences, Inc.$761MBEARQ -10$7.41+3.06%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news